LQDA News and Press, Liquidia Technologies Inc.

2026-03-14 10:50:24 ET More on State Street Health Care Select Sector SPDR ETF Sector Rotation: Healthcare XLV Should Be The Next Stop VT: Still The Best Approach To Passive Investing Market Sector Review: Extreme Market Bifurcation Eli Lilly tops growth ...

2026-03-05 18:03:28 ET Image source: The Motley Fool. Thursday, March 5, 2026, at 8:30 a.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading

2026-03-05 10:36:31 ET More on Liquidia Liquidia Corporation (LQDA) Q4 2025 Earnings Call Transcript Liquidia Appears Set For Strong 2026 On Further Share Gains Liquidia: Capturing Special Situation Gains And Longer-Term Gains Liquidia FY 2025 Earnings Previe...

2026-03-05 10:35:55 ET Liquidia Corporation (LQDA) Q4 2025 Earnings Call March 5, 2026 8:30 AM EST Company Participants Jason Adair - Chief Business Officer Roger Jeffs - CEO & Director Michael Kaseta - COO & CFO Scott Moomaw - Chief Commercial Office...

2026-03-05 06:39:43 ET More on Liquidia Liquidia Appears Set For Strong 2026 On Further Share Gains Liquidia: Capturing Special Situation Gains And Longer-Term Gains Liquidia Corporation (LQDA) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow ...

Achieved YUTREPIA ® net product sales of $148.3 million for the full year 2025 with $90.1 million in the fourth quarter More than 3,600 unique prescriptions received and 2,900 patients treated to date since launch in June 2025 Ended 2025 with $190.7 million in cash and cash equivalents, a...

Transportadora de Gas del Sur SA TGS (TGS) is expected to report $0.51 for Q4 2025 John Wiley & Sons Inc. (WLY) is expected to report $0.86 for Q3 2026 Foghorn Therapeutics Inc. (FHTX) is expected to report $-0.28 for Q4 2025 Costco Wholesale Corporation (COST) is expected to repo...

2026-03-04 11:11:47 ET Opaleye Management Inc. disclosed in a February 17, 2026, SEC filing that it sold 180,000 shares of Liquidia (NASDAQ:LQDA) , an estimated $5.12 million trade based on quarterly average pricing. According to a SEC filing dated February 17, 2026, Opaleye...

2026-03-04 10:37:07 ET More on Liquidia Liquidia Appears Set For Strong 2026 On Further Share Gains Liquidia: Capturing Special Situation Gains And Longer-Term Gains Liquidia Corporation (LQDA) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow ...

2026-02-27 07:05:53 ET In June 2025, Liquidia ( LQDA ) launched Yutrepia as a treatment for pulmonary hypertension, a relatively rare condition. The launch has gone well, and Liquidia has taken share and may continue to do so based on comments from their main competitor. This appear...